InvestSMART

Wellnex Life Limited (ASX: WNX) - Announcements

- Current share price for WNX : $0.060

ASX company news and announcements for Wellnex Life Limited (WNX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Wellnex Life Limited (WNX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Wellnex Life Limited (WNX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Wellnex Life Limited (WNX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$4 Appendix 4C and Quarterly Report for Sep 2026 Quarter 30 Oct 2026 9:09AM $0.066 $0.060 fallen by 9.09%
$4 Notice of Annual General Meeting/Proxy Form 29 Oct 2026 4:41PM $0.066 $0.060 fallen by 9.09%
$4 Ceasing to be a substantial holder 5 Oct 2026 4:36PM $0.082 $0.060 fallen by 26.83%
$4 Change of Director's Interest Notice 5 Oct 2026 4:34PM $0.082 $0.060 fallen by 26.83%
$4 Completion and Settlement of Sale of Pain Away 11 Sep 2026 4:13PM $0.081 $0.060 fallen by 25.93%
$4 Results of Meeting 8 Sep 2026 10:42AM $0.081 $0.060 fallen by 25.93%
$4 Change of Chief Financial Officer 31 Aug 2026 6:11PM $0.081 $0.060 fallen by 25.93%
$4 Appendix 4G and Corporate Governance Statement 31 Aug 2026 6:09PM $0.081 $0.060 fallen by 25.93%
$4 Wellnex Life Releases FY26 Annual Report 31 Aug 2026 6:01PM $0.081 $0.060 fallen by 25.93%
$4 FY26 Appendix 4E and Annual Report 31 Aug 2026 6:00PM $0.081 $0.060 fallen by 25.93%
$4 Notice of Extraordinary General Meeting/Proxy Form 7 Aug 2026 3:30PM $0.115 $0.060 fallen by 47.83%
$4 Sale of Pain Away for up to A$21.3 million 6 Aug 2026 4:35PM $0.055 $0.060 risen by 9.09%
$4 Appendix 4C and Quarterly Report for Jun 2026 Quarter 31 Jul 2026 2:11PM $0.052 $0.060 risen by 15.38%
$4 Initial Director's Interest Notice 12 Jun 2026 6:30PM $0.047 $0.060 risen by 27.66%
$4 Appointment of Non-Executive Director 12 Jun 2026 6:28PM $0.047 $0.060 risen by 27.66%
$4 Appendix 4C and Quarterly Report for Mar 2026 Quarter 30 Apr 2026 4:19PM $0.075 $0.060 fallen by 20%
$4 Extension of Loan Repayment 23 Apr 2026 9:03AM $0.075 $0.060 fallen by 20%
$4 Update on Loan Repayment 22 Apr 2026 9:48AM $0.072 $0.060 fallen by 16.67%
$4 Notification of cessation of securities - WNX 8 Apr 2026 10:25AM $0.075 $0.060 fallen by 20%
$4 Ceasing to be a substantial holder 7 Apr 2026 4:48PM $0.075 $0.060 fallen by 20%
$4 Cleansing Notice 2 Apr 2026 4:23PM $0.073 $0.060 fallen by 17.81%
$4 Application for quotation of securities - WNX 2 Apr 2026 4:21PM $0.073 $0.060 fallen by 17.81%
$4 Extension of Haleon Licensing and Supply Agreement 2 Apr 2026 9:39AM $0.073 $0.060 fallen by 17.81%
$4 Proposed issue of securities - WNX 27 Mar 2026 4:19PM $0.079 $0.060 fallen by 24.05%
$4 Issue of Shares 27 Mar 2026 4:19PM $0.079 $0.060 fallen by 24.05%

1 - 25 of 458 results

Page 1 of 19

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.